Skip to content

Oncology Support iconOncology Support

Breast and prostate cancer hormone therapies, targeted cancer medicines and a supportive antiemetic make up this range. Nolvadex, Altraz and Aromasin are among the recognised names here.

Nolvadex

Tamoxifen

10mg · 20mg

Tamoxifen tablets for breast cancer. It blocks oestrogen from attaching to hormone-sensitive breast cancer cells.

From$0.67/ tabletView

Altraz

Anastrozole

1mg

Anastrozole tablets for breast cancer. It blocks the aromatase enzyme, cutting off the oestrogen supply that certain tumours depend on.

From$3.92/ tabletView

Aromasin

Exemestane

25mg

Exemestane tablets for breast cancer. It lowers oestrogen levels in postmenopausal women by permanently blocking the aromatase enzyme.

From$3.56/ tabletView

Casodex

Bicalutamide

50mg

Bicalutamide tablets for prostate cancer. It blocks the effect of testosterone on cancer cells and is usually taken alongside another hormone treatment.

From$8.13/ tabletView

Methotrexate Tablets

Methotrexate

2.5mg · 5mg · 7.5mg · 10mg

Methotrexate tablets for rheumatoid arthritis and psoriasis. It calms the immune system's attack on joints and skin.

From$0.41/ tabletView

Zofran

Ondansetron

4mg · 8mg

Ondansetron tablets for nausea and vomiting after chemotherapy or surgery. It blocks a chemical that triggers the vomiting reflex.

From$0.56/ tabletView

Efudex

Fluorouracil

5%

Fluorouracil cream for actinic keratosis and some skin cancers. It destroys precancerous and cancerous cells by blocking their rapid division.

From$36.40/ tubeView

Hydrea

Hydroxycarbamide

500mg

Hydroxycarbamide tablets for chronic myeloid leukaemia and certain head and neck cancers. It works by stopping cancer cells from dividing.

From$2.12/ tabletView

Gleevec

Imatinib

400mg

Imatinib tablets for chronic myeloid leukaemia and stomach tumours. It disables the abnormal protein that fuels the growth of leukaemia cells.

From$10.63/ tabletView

Sprycel

Dasatinib

50mg

Dasatinib tablets for chronic myeloid and acute lymphocytic leukaemia. It blocks proteins that drive leukaemia cell growth.

From$129.00/ bottleView

Tarceva

Erlotinib

100mg

Erlotinib tablets for non-small cell lung and pancreatic cancer. It targets a protein that helps these cancers grow.

From$16.27/ tabletView

Key points

  • Cancer medicines here split into two roles: most act directly on a tumour, while a smaller group provides supportive care for treatment effects.
  • Efudex is applied topically here, listed for actinic keratosis and superficial basal cell carcinoma rather than a systemic cancer treatment.
  • Three of the twelve medicines here, Hydrea, Gleevec and Sprycel, are listed for chronic myeloid leukaemia.
  • Methotrexate Tablets is listed for rheumatoid arthritis and psoriasis as well as acute lymphocytic leukaemia, spanning antirheumatic and antineoplastic roles.

Tamoxifen, anastrozole and exemestane for breast cancer

Tamoxifen is the ingredient in both Nolvadex and Tamoxifen Tablets, listed for breast cancer; Nolvadex is also listed under Women’s Health. Anastrozole is the aromatase inhibitor in Altraz, and exemestane is the aromatase inhibitor in Aromasin, each also listed for breast cancer. Casodex contains bicalutamide, an androgen receptor inhibitor listed for prostate cancer.

Targeted therapies and supportive care

Gleevec contains imatinib, also listed for gastrointestinal stromal tumours. Sprycel contains dasatinib, also listed for acute lymphocytic leukaemia. Hydrea contains hydroxycarbamide, also listed for head and neck cancer and sickle cell anaemia. Tarceva contains erlotinib, listed for non-small cell lung cancer and pancreatic cancer. Zofran contains ondansetron, supportive care here for chemotherapy-induced and postoperative nausea and vomiting rather than a tumour-directed treatment.

Further reading